SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Fregni F, Pascual-Leone A. Curr. Psychiatry Rep. 2005; 7(5): 381-390.

Copyright

(Copyright © 2005, Holtzbrinck Springer Nature Publishing Group)

DOI

10.1007/s11920-005-0041-4

PMID

unavailable

Abstract

Depression is commonly as sociated with neurologic disorders. Although depression in neurologic conditions often is associated with a negative impact on quality of life, it frequently is poorly managed. Some factors, such as a multidrug regimen, lack of efficacy, and side effects of antidepressants may explain why depression is not adequately treated in patients with neurologic disorders. Therefore, this population needs new approaches for depression treatment, and repetitive transcranial magnetic stimulation (rTMS) may be one of them because it has been shown to be effective for the treatment of depression alone and depression in certain neurologic diseases such as Parkinson's disease and stroke. rTMS is a noninvasive, focal, and painless treatment associated with few, mild side effects. It may be effective in the treatment of neurologic diseases such as Parkinson's disease, stroke, and epilepsy. In this paper, we discuss the potential risks and benefits of rTMS treatment for depression in Parkinson's disease, epilepsy, stroke, multiple sclerosis, and Alzheimer's disease. Lastly, a framework that includes the parameters of stimulation (intensity, frequency, number of pulses, and site of stimulation) for the treatment of depression in neurologic diseases is proposed. Copyright © 2005 by Current Science Inc.


Language: en

Keywords

human; cognition; suicide; incidence; safety; quality of life; depression; prevalence; stroke; clinical trial; risk assessment; treatment outcome; review; epilepsy; anticonvulsive agent; disease association; drug metabolism; fluoxetine; tricyclic antidepressant agent; headache; electroconvulsive therapy; Alzheimer disease; nonhuman; placebo; seizure; drug efficacy; drug tolerability; neurologic disease; brain function; electric current; brain atrophy; Parkinson disease; anticholinergic effect; electroencephalography; liver metabolism; multiple sclerosis; neck pain; frequency analysis; electrostimulation therapy; transcranial magnetic stimulation; diathermy; evoked cortical response

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print